Add to Cart View Cart/Checkout More Products

Volume 7, 2003 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2003 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 7 No. 1 January/February 2003 Terrorism
Vol. 7 No. 2 March/April 2003 Terrorism
Vol. 7 No. 3 May/June 2003 Diabetes and Wound Care
Vol. 7 No. 4 July/August 2003 After the Women's Health Initiative Trial
Vol. 7 No. 5 September/October 2003 After the Women's Health Initiative Trial
Vol. 7 No. 6 November/December 2003 Compounding for Investigational Studies

Articles
Volume/IssuePageTitle
Vol. 7 No. 1 10 Compounding for the Effects of Weapons of Mass Destruction
Vol. 7 No. 1 17 Diabetes Mellitus: Pathophysiology and Complications
Vol. 7 No. 1 21 Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vol. 7 No. 1 24 Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD.
Vol. 7 No. 1 27 Equine Cushing’s Syndrome
Vol. 7 No. 1 32 Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 2
Vol. 7 No. 1 37 Packaging Choices for Compounded Materials
Vol. 7 No. 1 42 Technology Spotlight: Barrier Isolators
Vol. 7 No. 1 44 Determining the Availability of a Commercial Drug
Vol. 7 No. 1 46 Calculations
Vol. 7 No. 1 48 Featured Excipient: Flavor Enhancing Agents
Vol. 7 No. 1 51 Basics of Compounding for Terrorist Attacks, Part 1
Vol. 7 No. 1 55 Amoxicillin 125-mg/5-mL and 250-mg/5-mL Suspensions
Vol. 7 No. 1 56 Atropine 1-mg Gelatin Troches
Vol. 7 No. 1 57 Atropine Sulfate 0.1% for Inhalation
Vol. 7 No. 1 58 Atropine Sulfate 0.5-mg/mL Injection
Vol. 7 No. 1 59 Gentamicin Sulfate 40-mg/mL Injection
Vol. 7 No. 1 60 Levofloxacin 250-mg/5mL Oral Liquid
Vol. 7 No. 1 60 Ofloxacin 250-mg/5-mL Oral Liquid
Vol. 7 No. 1 61 Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid
Vol. 7 No. 1 62 Ribavirin 200-mg Capsules
Vol. 7 No. 1 63 Sodium Hypochlorite Disinfectant Solutions
Vol. 7 No. 1 64 Vancomycin HCl 50-mg/mL Oral Solution
Vol. 7 No. 1 65 Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes
Vol. 7 No. 1 68 Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes
Vol. 7 No. 1 71 Use of Cysteine Hydrochloride Injection to Increase the Solubility of Calcium and Phosphates in FreAmine III-Containing Parenteral Nutrition Solutions
Vol. 7 No. 1 78 Wish You Were Here: Deutsche Apotheken Museum (German Museum of Pharmacy)
Vol. 7 No. 1 80 Postcription: Future Trends in High Technology Pharmaceutical Compounding
Vol. 7 No. 2 84 Book and Literature Reviews
Vol. 7 No. 2 88 Legal & Ethical Issues for Pharmacy Websites
Vol. 7 No. 2 94 Panel Discussion: Prohormones
Vol. 7 No. 2 101 Profile of a Practice: Building a Compounding Pharmacy Practice from the Ground Up: Prescription Compounding Solutions, Medford, Oregon
Vol. 7 No. 2 106 Veterinary Transdermal Medications: A to Z
Vol. 7 No. 2 114 Autoclaves for the Sterilization of Compounded Parenteral Products
Vol. 7 No. 2 118 Barcode System and Computerized Balance Speed Compounding and Enhance Accuracy
Vol. 7 No. 2 120 Technology Spotlight: Electronic Balances with Printer and Draft Shield
Vol. 7 No. 2 124 Accuracy of Small-Volume Containers
Vol. 7 No. 2 126 Autoclave Efficiency Validation
Vol. 7 No. 2 128 Calculations
Vol. 7 No. 2 129 Basics of Compounding for Terrorist Attacks, Part 2
Vol. 7 No. 2 131 Amoxicillin 250-mg Troches
Vol. 7 No. 2 131 Amoxicillin 125-mg Suppositories
Vol. 7 No. 2 131 Chloramphenicol 250-mg Capsules
Vol. 7 No. 2 131 Chloramphenicol 150-mg/5-mL Suspension
Vol. 7 No. 2 131 Cidofovir Suppositories
Vol. 7 No. 2 131 Ciprofloxacin Oral Suspension
Vol. 7 No. 2 132 Clindamycin HCl 150-mg Capsules
Vol. 7 No. 2 132 Clindamycin Phosphate 150-mg Capsules
Vol. 7 No. 2 132 Clindamycin 10-mg/mL Oral Suspension
Vol. 7 No. 2 132 Doxycycline HCl 100-mg Capsules
Vol. 7 No. 2 132 Erythromycin 200-mg Troches
Vol. 7 No. 2 132 Erythromycin 250-mg Suppositories
Vol. 7 No. 2 132 Penicillin G Potassium 20,000,000-units Injection
Vol. 7 No. 2 132 Penicillin G Potassium 1,000,000-unit Injection
Vol. 7 No. 2 132 Ribavirin 33-mg/mL Injection
Vol. 7 No. 2 132 Rifampin 10-mg/mL Oral Suspension
Vol. 7 No. 2 132 Rifampin 150-mg Capsules
Vol. 7 No. 2 132 Rifampin 3-mg/mL Intravenous Infusion
Vol. 7 No. 2 132 Streptomycin Sulfate 400-mg/mL Injection
Vol. 7 No. 2 132 Tetracycline 125-mg/5-mL Syrup
Vol. 7 No. 2 132 Tetracycline HCl 20-mg/mL Intravenous Injection
Vol. 7 No. 2 132 Tetracycline HCl 250-mg Capsules
Vol. 7 No. 2 133 Tetracycline HCl 250-mg Suppositories
Vol. 7 No. 2 133 Vancomycin HCl 250-mg Capsules
Vol. 7 No. 2 133 Albuterol Sulfate 0.5% Inhalation Solution
Vol. 7 No. 2 133 Dimercaptosuccinic Acid 250-mg Capsules
Vol. 7 No. 2 133 Sodium Thiosulfate-Sodium Nitrate Solution
Vol. 7 No. 2 133 Potassium Iodide Saturated Solution
Vol. 7 No. 2 134 Lorazepam 2-mg Gelatin Troches
Vol. 7 No. 2 134 Lorazepam 2-mg Polyethlene Glycol Troches
Vol. 7 No. 2 134 Oral Liquid Suspending Vehicle
Vol. 7 No. 2 135 Diazepam 5-mg/mL Injection
Vol. 7 No. 2 136 Dimercaprol 100-mg/mL Injection USP
Vol. 7 No. 2 137 Dimercaptopropanesulfonate Sodium 50-mg/mL Injection
Vol. 7 No. 2 138 Lorazepam 2-mg Sublingual Tablets
Vol. 7 No. 2 139 Mafenide Acetate 85 mg/g Cream USP
Vol. 7 No. 2 140 Pralidoxime Chloride 50-mg/mL Injection
Vol. 7 No. 2 141 Silver Sulfadiazine 1% Cream
Vol. 7 No. 2 142 Sodium Bicarbonate 8.4% Injection USP
Vol. 7 No. 2 143 Sodium Nitrite 3% Injection USP
Vol. 7 No. 2 144 Sodium Thiosulfate 25% Injection USP
Vol. 7 No. 2 145 Featured Excipient: Plasticizers
Vol. 7 No. 2 149 Stability of Clindamycin Phosphate in AutoDose Infusion System Bags
Vol. 7 No. 2 152 Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 7 No. 2 155 Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis
Vol. 7 No. 2 160 PostScription: Sterile Product Admixture Preparation
Vol. 7 No. 3 164 Book & Literature Reviews
Vol. 7 No. 3 170 Five Compounds for Treating Diabetes-Related Conditions
Vol. 7 No. 3 171 Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO
Vol. 7 No. 3 171 Sildenafil 25-mg Troches
Vol. 7 No. 3 171 Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection
Vol. 7 No. 3 171 Misoprostol 0.0024% and Phenytoin 5% Diabetic Ulcer Cream
Vol. 7 No. 3 171 Nifedipine 100- mg/mL in PLO
Vol. 7 No. 3 176 Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Vol. 7 No. 3 180 The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP
Vol. 7 No. 3 183 ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl)
Vol. 7 No. 3 183 Ketoprofen 10% in PLO
Vol. 7 No. 3 183 Methimazole 5 mg/0.1 mL in PLO (Vet)
Vol. 7 No. 3 184 Wish You Were Here: The Pearson Museum, Springfield, Illinois
Vol. 7 No. 3 188 Treating Canine Hepatic Disease
Vol. 7 No. 3 193 Incubators
Vol. 7 No. 3 195 Further Clarification of HIPAA Regulations
Vol. 7 No. 3 197 Software for the Compounding Pharmacist: An Update
Vol. 7 No. 3 206 Technology Spotlight: Tube Sealers
Vol. 7 No. 3 208 Accuracy of Graduated Cylinders
Vol. 7 No. 3 212 Calculations
Vol. 7 No. 3 213 Product Containment in the Compounding Laboratory
Vol. 7 No. 3 215 Dexamethasone Phosphate 0.05% Ophthalmic Ointment
Vol. 7 No. 3 216 Dexamethasone Phosphate 0.1% Topical Cream
Vol. 7 No. 3 217 Dimenhydrinate 5-mg/mL Oral Liquid
Vol. 7 No. 3 218 Epinephrine Bitartrate 2% Ophthalmic Solution
Vol. 7 No. 3 219 Ergotamine Tartrate 2-mg Sublingual Tablets
Vol. 7 No. 3 220 Hyoscyamine Sulfate 0.125-mg and Phenobarbital 15-mg/mL Oral Drops
Vol. 7 No. 3 221 Methadone HCl 5-mg/mL Injection
Vol. 7 No. 3 222 Minocycline 10-mg/mL Oral Liquid
Vol. 7 No. 3 223 Phenytoin 6-mg/mL Oral Liquid
Vol. 7 No. 3 224 Tetracycline HCl 2.2-mg/mL Topical Solution
Vol. 7 No. 3 225 Quality-Control Analytical Methods: Principles of pH
Vol. 7 No. 3 228 Standard Operating Procedure: Incubator Temperature Monitoring
Vol. 7 No. 3 230 Stability of Amikacin Sulfate in AutoDose Infusion System Bags
Vol. 7 No. 3 233 Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Vol. 7 No. 3 240 PostScription: Too Many Compounders?
Vol. 7 No. 4 244 Book Reviews
Vol. 7 No. 4 246 Literature Review
Vol. 7 No. 4 250 A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Vol. 7 No. 4 258 Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
Vol. 7 No. 4 266 Sensitization Therapy for Warts
Vol. 7 No. 4 270 Dinitrochlorobenzene 0.5% to 2.0% in Acetone
Vol. 7 No. 4 270 Dinitrochlorobenzene 0.1% to 1 % in Hydrophilic Petrolatum
Vol. 7 No. 4 270 Diphenylcyclopropenone 0.01% to 0.1% in Acetone
Vol. 7 No. 4 270 Squaric Acid Dibutyl Ester 0.03% to 3.0 in Acetone
Vol. 7 No. 4 270 Cantharidine 0.7% Topical
Vol. 7 No. 4 270 Fluorouracil 5% Gel
Vol. 7 No. 4 270 Podophyllum 25% in Compound Tincture of Benzoin
Vol. 7 No. 4 270 Podophyllum 1% and Salicylic Acid 3% in Flexible Collodion
Vol. 7 No. 4 270 Salicylic Acid 40% Ointment
Vol. 7 No. 4 272 Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Vol. 7 No. 4 272 Rhus Tox Solution 2X
Vol. 7 No. 4 272 Rhus Tox Solution 3X
Vol. 7 No. 4 272 Rhus Tox Solution 4X
Vol. 7 No. 4 272 Rhus Tox Solution 5X
Vol. 7 No. 4 272 Rhus Tox Solution 6X
Vol. 7 No. 4 272 Rhus Tox Solution 7X
Vol. 7 No. 4 272 Rhus Tox Solution 8X
Vol. 7 No. 4 272 Rhus Tox Solution 9X
Vol. 7 No. 4 272 Rhus Tox Solution 10X
Vol. 7 No. 4 272 Rhus Tox Solution 11X
Vol. 7 No. 4 272 Rhus Tox Solution 12X
Vol. 7 No. 4 272 Rhus Tox 6X/12X Solution
Vol. 7 No. 4 277 HIPAA Privacy and Security for Providers: The Basics
Vol. 7 No. 4 281 Containment of Hazardous Particulates in the Compounding Pharmacy
Vol. 7 No. 4 286 Technology Spotlight: A USP-Grade Water System
Vol. 7 No. 4 288 Basics of Compounding for Raynaud's Disease
Vol. 7 No. 4 291 Nifedipine in PLO Gel
Vol. 7 No. 4 291 Nitroglycerin 0.2% Ointment
Vol. 7 No. 4 291 Coenzyme Q10 100-mg-in-Oil Capsules
Vol. 7 No. 4 291 Zinc, Magnesium, Caldium and Vitamin D3 Oral Liquid
Vol. 7 No. 4 292 How to Handle a Product Recall
Vol. 7 No. 4 294 Calculations
Vol. 7 No. 4 295 Brompheniramine Maleate 2-mg/5-mL Oral Liquid
Vol. 7 No. 4 296 Chlorpheniramine Maleate 10-mg/mL Injection
Vol. 7 No. 4 297 Chlorpromazine HCl 30-mg/mL Oral Concentrate
Vol. 7 No. 4 298 Desonide 0.05% Otic Liquid
Vol. 7 No. 4 299 Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection
Vol. 7 No. 4 300 Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection
Vol. 7 No. 4 301 Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection
Vol. 7 No. 4 302 Methocarbamol 400-mg and Aspirin 325-mg Capsules
Vol. 7 No. 4 303 Perphenazine 4-mg and Amitriptyline HCl 10-mg capsules
Vol. 7 No. 4 304 Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid
Vol. 7 No. 4 305 Quality-Control Analytical Methods: Viscosity Measurements
Vol. 7 No. 4 310 Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 7 No. 4 313 Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations
Vol. 7 No. 4 320 Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics?
Vol. 7 No. 5 324 Book and Literature Reviews
Vol. 7 No. 5 330 A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Vol. 7 No. 5 339 Patient Handout - Hormone Replacement Therapy
Vol. 7 No. 5 341 The Role of the Pharmacist in Diabetes Care
Vol. 7 No. 5 345 Understanding Feline Hyperthyroidism
Vol. 7 No. 5 350 Profile of a Practice: Don West, RPh, Lloyd Center Pharmacy, Portland, Oregon
Vol. 7 No. 5 354 Vancomycin Pluronic Gel
Vol. 7 No. 5 354 Sterile Vancomycin Pluronic Gel for Implantation in the Chest-Wall Cavity to Treat Resistant Pneumococcus
Vol. 7 No. 5 358 NDC Numbers: A New Approach
Vol. 7 No. 5 361 Application of USP-NF Standards to Pharmacy Compounding
Vol. 7 No. 5 364 Technology Spotlight: Respiratory Vial Sealers
Vol. 7 No. 5 366 Basics of Compounding for Pediculosis
Vol. 7 No. 5 368 Malathion 0.5% Topical Lotion
Vol. 7 No. 5 368 Ivermectin 1% Crème Rinse
Vol. 7 No. 5 369 Ivermectin 1% Lotion
Vol. 7 No. 5 369 Head Lice Repellant Spray
Vol. 7 No. 5 370 Standard Operating Procedure: Incubator Cleaning
Vol. 7 No. 5 372 Calculations
Vol. 7 No. 5 373 Chloramphenicol 1% Topical Ointment
Vol. 7 No. 5 374 Guanethidine Monosulfate 10-mg and Hydrochlorothiazide 25-mg Capsules
Vol. 7 No. 5 375 Indomethacin 50-mg Suppositories
Vol. 7 No. 5 376 Isoniazid 10-mg/mL Oral Solution
Vol. 7 No. 5 377 Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules
Vol. 7 No. 5 378 Perphenazine 5-mg/mL Injection
Vol. 7 No. 5 379 Phenylbutazone 100-mg Capsules
Vol. 7 No. 5 380 Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules
Vol. 7 No. 5 381 Thioridazine HCl 100-mg/mL Concentrated Solution
Vol. 7 No. 5 382 Ursodiol 150-mg Capsules
Vol. 7 No. 5 383 Quality-Control Analytical Methods: Refractometry
Vol. 7 No. 5 386 Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder
Vol. 7 No. 5 389 Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Vol. 7 No. 5 394 Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings
Vol. 7 No. 5 399 Postcriptions: Compounding Paradox: Taught Less and Practiced More
Vol. 7 No. 5 401 An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices
Vol. 7 No. 6 418 PreScription: Take Care with Terminology for Altered- and Slow-release Formulations
Vol. 7 No. 6 420 Book & Literature Reviews
Vol. 7 No. 6 426 Sore Nipples in Breastfeeding Mothers: Causes and Treatments
Vol. 7 No. 6 430 Mupirocin 1%, Betamethasone 0.05%, and Miconazole 2% Nipple Ointment
Vol. 7 No. 6 430 Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 0.25% Nipple Ointment
Vol. 7 No. 6 430 Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 2.5% Nipple Ointment
Vol. 7 No. 6 436 Compounding for Investigational Studies: The Experience of Ken Hughes, RPh
Vol. 7 No. 6 441 Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Vol. 7 No. 6 449 Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Vol. 7 No. 6 454 A Foot in the Door: Marketing Tips
Vol. 7 No. 6 458 Technology Spotlight: Automated Prescription-Dispensing Systems
Vol. 7 No. 6 460 Basics of Compounding for Dry-Skin Conditions
Vol. 7 No. 6 462 Wool Alcohols Ointment
Vol. 7 No. 6 462 Water-Absorbing Ointment
Vol. 7 No. 6 462 Natural Emollient Oil
Vol. 7 No. 6 462 Emulsion Base to be Individualized
Vol. 7 No. 6 463 Premixed Oil Phase for Preparing Oil-in-Water (O/W) Emulsions
Vol. 7 No. 6 463 O/W Emulsion
Vol. 7 No. 6 463 Lotion with Cyclomethicone
Vol. 7 No. 6 463 Water-Repelling Lip-Balm Stick
Vol. 7 No. 6 463 Lip-Balm Stick (Basic Formula for Individualizing)
Vol. 7 No. 6 463 Water-Repelling Lip Ointment
Vol. 7 No. 6 463 Lip Ointment (Basic Ointment for Individualizing)
Vol. 7 No. 6 464 Storage of Bulk Chemicals and Finished Preparations
Vol. 7 No. 6 466 Calculations
Vol. 7 No. 6 467 Bacitracin 500-U/g Ophthalmic Ointment
Vol. 7 No. 6 468 Chloramphenicol 0.5% Ophthalmic Solution
Vol. 7 No. 6 469 Clotrimazole 500-mg Vaginal Suppositories
Vol. 7 No. 6 470 Ergoloid Mesylate 1-mg/mL Oral Liquid
Vol. 7 No. 6 471 Meclocycline Sulfosalicylate 1% Cream
Vol. 7 No. 6 472 Methadone HCl 2.5-mg Capsules
Vol. 7 No. 6 473 Perphenazine 2.5-mg/5-mL Syrup
Vol. 7 No. 6 474 Sulfasalazine 250-mg/5-mL Oral Liquid
Vol. 7 No. 6 475 Tramadol HCl 100-mg Capsules
Vol. 7 No. 6 476 Triprolidine HCl 2.5-mg Capsules
Vol. 7 No. 6 477 Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids
Vol. 7 No. 6 481 Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers
Vol. 7 No. 6 485 Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension
Vol. 7 No. 6 490 Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations
Vol. 7 No. 6 495 PostScription: Changing Pharmacy Regulations Could Affect US Compounders